๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hemostatic effects of hormonal stimulation in patients with metastatic prostate cancer

โœ Scribed by Dr. Hamid Al-Mondhiry; Andrea Manni; John Owen; Robert Gordon


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
518 KB
Volume
28
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of newly diagnosed metastatic
โœ Gerald P. Murphy; Sunmolu Beckley; Mark F. Brady; T. Ming Chu; Jean B. Dekernion ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 699 KB

by the National Prostatic Cancer Project randomized newly diagnosed metastatic prostate cancer patients to DES 1 mg orally three times daily or orchiectomy; or DES, 1 mg, three times daily, plus cyclophosphamide at 1 mg/m2 iv every three weeks, or cyclophosphamide 1 g/m2 iv every three weeks plus es

Circulating levels of interleukin-6 in p
โœ Drachenberg, Darrel E.; Elgamal, Abdel-Aziz A.; Rowbotham, Ron; Peterson, Mary; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 191 KB ๐Ÿ‘ 2 views

BACKGROUND. ) is a cytokine that plays a central role in host defense due to its wide range of immune and hematopoietic activities. It is found in high levels in human ejaculate, and has recently been found to regulate prostate-specific protein expression in prostate cancer cells through nonsteroida